Recent Updates
Recently added Catalysts
GRDX Negative Sentiment Score: 25/100

Eric Corbett 100 Long Branch Avenue Unit 21 Etobicoke, Ontario, M8W 0C1 CANADA Via Email (jason@accessalternative.com; edborkowski@gmail.com)

Key Takeaway: Eric Corbett has announced his resignation from the Board of Directors of Entero Therapeutics Inc., effective November 28, 2025. The resignation stems from fundamental disagreements with the management and the Board's policies and practices. This internal conflict may raise concerns regarding the company's governance and future strategic decisions.

Market Sentiment Analysis

CONCERNS & RISKS

  • Resignation indicates significant internal conflict within the Board.
  • Fundamental disagreements with management highlight potential governance issues.
  • Concerns expressed may lead to instability in strategic direction.

Full Press Release Details

100 Long Branch Avenue Unit
Etobicoke, Ontario, M8W 0C1
Re: Resignation from the Entero Therapeutics Inc.
Board of Directors Dear Messrs. Borkowski and Sawyer,
I am writing to tender my resignation
from the Board of Directors of Entero Therapeutics Inc. (the "Company"), effective November 28, 2025 due to fundamental disagreements
with Management and the Board's policies, practices and procedures. The circumstances leading to my resignation involve concerns

Frequently Asked Questions

What is the reason for the resignation?

The resignation is due to fundamental disagreements with Management and Board policies.

When is the resignation effective?

The resignation is effective on November 28, 2025.

Who submitted the resignation?

The resignation was submitted by a board member of Entero Therapeutics Inc.

What company is involved in the resignation?

The resignation involves Entero Therapeutics Inc.

Last updated: Nov 28, 2025